logo
Goldman Sachs funds $600 million for Jubilant Bharti's Coca-Cola India bottling unit deal. All you need to know

Goldman Sachs funds $600 million for Jubilant Bharti's Coca-Cola India bottling unit deal. All you need to know

Minta day ago

Goldman Sachs Asset Management has provided $600 million to Jubilant Bhartia Group to partially fund its acquisition of a 40 per cent stake in Coca-Cola Co's bottling unit in India, according to Bloomberg.
The deal was announced in December and received approval from the Competition Commission of India on May 1, 2025.
Goldman Sachs' hybrid fund financed this equity portion by subscribing to the convertible preference shares issued by the group.
The fund is part of the investment bank's private credit strategy, which sits between traditional debt and equity, and is usually longer in tenure.
Convertible preference shares are one of the many ways through which companies can raise money to fund their operations and expansion plans. The lending companies can choose to do so because it enables them to avoid taking on debt, along with limiting the potential dilution of selling additional common stock.
In December, Coca-Cola announced that Jubilant Bhartia is set to acquire a minority stake of 40 per cent in Hindustan Coca-Cola Holdings Pvt.
Coca-Cola is the parent company of the soft drink maker's largest bottler in India called Hindustan Coca-Cola Beverages Pvt.
The total acquisition will cost Jubilant Bhartia $1.5 billion, as reported byBloomberg.
Other than the funding received by the company from Goldman Sachs, the pizza-to-pharmaceuticals conglomerate will raise $600 million in equity and $300 million in debt to fund the remaining $900 million required for the acquisition.
Jubilant Bhartia Group operates in sectors such as pharmaceuticals, food services, and energy solutions. It has franchise rights for global brands like Domino's, Popeyes, and Dunkin'. The group also has businesses in pharmaceuticals, which include contract research, novel drug development, and life science ingredients.
In India, The Coca-Cola Co bottles products such as Thums-Up, Sprite, Fanta, Limca and flagship brand Coca-Cola through subsidiary Hindustan Coca-Cola Beverages Pvt Ltd. It also owns a set of independent bottling companies.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Goldman funds $600 million equity for Coca-Cola India unit sale
Goldman funds $600 million equity for Coca-Cola India unit sale

Time of India

time15 hours ago

  • Time of India

Goldman funds $600 million equity for Coca-Cola India unit sale

Goldman Sachs Asset Management has provided $600 million to partially fund the equity investment needed by Indian conglomerate Jubilant Bhartia Group for its purchase of a 40% stake in The Coca-Cola Co.'s bottling unit in India, according to people familiar with the matter. Goldman Sachs Asset Management's hybrid fund financed this equity portion by subscribing to the convertible preference shares issued by the group, said the people, who asked not to be named discussing a private matter. The fund — which is part of the investment bank's private credit strategy — sits between traditional debt and equity, and is usually longer in tenure. Convertible preference shares is one of the many ways companies can raise capital to fund their operations and expansion. They can choose to do so because it enables them to avoid taking on debt, while limiting the potential dilution of selling additional common stock. Goldman Sachs and Jubilant Bhartia declined to comment. Coca-Cola in December announced that Jubilant Bhartia will acquire a minority stake in Hindustan Coca-Cola Holdings Pvt., the parent company of the soft drink maker's largest bottler in India called Hindustan Coca-Cola Beverages Pvt. The total acquisition cost is $1.5 billion, the people said. The pizza-to-pharmaceuticals conglomerate will fund the remaining $900 million required for the acquisition with $600 million of equity and $300 million in debt, the people added. Two subsidiaries of the group — Jubilant BevCo and Jubilant Beverages — recently issued rupee-denominated bonds totaling $658 million-equivalent to fund the deal, Bloomberg News reported. Jubilant Bhartia's purchase of a stake in the beverage giant joins a series of foreign firms looking to divest part of their shareholding in local arms. In December, the Indian unit of South Korea-based LG Electronics Inc. filed for an initial public offering, seeking to tap investors in the South Asian country's booming market. Earlier last year, British American Tobacco Plc raised $2 billion selling shares in its Indian partner. --With assistance from Divya Patil.

UP inks Rs 435cr MoUs at Ahmd roadshow
UP inks Rs 435cr MoUs at Ahmd roadshow

Time of India

time21 hours ago

  • Time of India

UP inks Rs 435cr MoUs at Ahmd roadshow

Lucknow: Inviting pharma sector players to come and invest in UP during a roadshow in Ahmedabad on Friday, CEO of UP state industrial development authority (UPSIDA), Mayur Maheshwari said that a new era for the pharma sector is taking place in UP. "UP is developing a bulk drug pharma park on 1,472.33 acre in Lalitpur, with a proposed investment of approximately Rs250 crore. This project is a significant step towards making the country self-reliant in the pharmaceutical sector and establishing India as the 'Pharmacy of the world'," he said, adding, "it will not only attract substantial investment but also create new employment opportunities for the skilled workforce in the state. " Several agreements were signed by UPSIDA with pharma companies on the occasion. The list includes CSL Lifesciences Private Limited, which proposed an investment of Rs 200 crore for establishing an intravenous bottle plant and oral solid dosage plant within the next two years. Likewise, Medihealth Diagnostic Pvt Ltd will establish a healthcare unit on 4,200 sqmt in Lalitpur, while Gaman Irradiation Company will invest Rs 35 crore in a skin treatment and irradiation unit. Creating employment for 150 people, the project will be implemented in 24-36 months. Additionally, Obmed Pharma has decided to invest Rs 200 crore to establish a formulation unit. Spread across five acre of land in Lalitpur, the unit will create employment for around 100 people. Several business-to-govt meetings were held, where detailed discussions on investment-related topics took place between industry representatives and govt officials. Earlier, in the welcome address, convenor of CII Gujarat pharma and healthcare panel, Swapnil Shah highlighted investment opportunities in UP. Advisor to UP CM, GN Singh said, "UP emerged as the most suitable state for investment in the pharma sector". He shared detailed information about the efforts made by the state govt to empower the pharma sector. An 'Open House' session followed, where participants engaged in direct dialogue with state govt officials to resolve their queries and concerns. The programme concluded with a vote of thanks by chairman of Shalby Ltd, Shanay Shah. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

UP performing on many parameters, demand for higher share in central taxes justified: Khanna
UP performing on many parameters, demand for higher share in central taxes justified: Khanna

Time of India

timea day ago

  • Time of India

UP performing on many parameters, demand for higher share in central taxes justified: Khanna

1 2 Lucknow: Days after the chairman of 16th Finance Commission Arvind Panagariya said that Uttar Pradesh, like many other states, had demanded increase in state's share from existing 41% to 50%, state finance minister Suresh Khanna said that such a demand has been raised by other states too and it is justified as UP has being doing better on several parameters. The UP govt's thrust before the 16th Finance Commission was on UP's share in central taxes which should be 20.47% against 17.93% it got in 15th Finance Commission, the finance minister told TOI. Sources said that even if UP does not get the demanded share of 20.47%, it should get at least 19.76% of central taxes, which UP got during the 13th Finance Commission between 2010 and 2015. The meeting, which was also attended by Chief Minister Yogi Adityanath, primarily focused on how much money is required by the state and why. Talking to TOI on the issue, Khanna said: "The demand is justified as UP has done better on several parameters. UP has fared well in tax effort, which is one of the criteria of the Finance Commission for allocating money. UP has collected over Rs 2.12 lakh crore in state's own tax collection. UP's own tax collection comprises state GST and VAT which stood over Rs 1.14 lakh crore." On the state's demand to increase UP's share to 20.47% of the central taxes, Khanna said that during the 14th Finance Commission, the tax share stood at 17.95% for UP which came down to 17.93% in 15th Finance Commission. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với sàn môi giới tin cậy IC Markets Tìm hiểu thêm Undo Khanna said that UP has done better not only in its own tax revenue but also performed better in financial management and discipline with FRBM limit remaining within the permissible limit of 3%. Khanna said since UP did not have its own natural resources, its demands were just and acceptable. He said even under forest index, which is also one of the criteria, the UP govt has planted over 200 crore trees of which over 70% have survived. But the finance commission counts forest covered areas if tree plantation is not done densely. "The demand to keep tree plantation in the forest criteria was also raised before the Finance Commission," Khanna said. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store